Gao et al. found that silencing of lncRNA LEF1-AS1 reduced EZH2 expression to repress hepatocellular carcinoma progression by disruption of CEBPB interaction with CDCA7 [33]. This evidence concerns the gene EZH2 and hepatocellular carcinoma.